Skip to main content
. 2016 May 8;2016(5):CD010529. doi: 10.1002/14651858.CD010529.pub2

Ozkul 2014.

Methods Single centre, prospective RCT comparing rapid and standard drainage prior to talc slurry pleurodesis (Turkey)
Participants Inclusion: potentially recurrent histologically &/or cytologically proven malignant pleural effusion (all cell types)
Exclusion: participants whose lung did not expand; endobronchial lesion; suitable for curative therapy
79 participants randomised
Interventions All participants underwent insertion of a 12 Fr chest drain in the posterior axillary lune with local anaesthetic (bupivacaine) and IM ketorolac
Rapid group: 1 litre drained every eight hours until complete drainage. Then talc slurry administered once CXR showed complete fluid evacuation and no trapped lung
Standard group: drainage of a maximum of 1.5 litre/day. Talc slurry administered once CXR showed complete fluid evaluation and no trapped lung and pleural fluid drainage < 300 ml/day
Outcomes Primary outcome: efficacy of pleurodesis assessed at 1, 2, 3, and 6 months
Secondary outcome: hospital length of stay
Notes people with trapped lung excluded from study entry
Pleurodesis efficacy defined using a combination of radiology and symptomatic effusion re‐accumulation
Not included in network meta‐analysis
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Internet‐based random‐number generator
Allocation concealment (selection bias) Unclear risk Not stated and no response from study authors
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Not possible to blind given nature of two treatment groups with such different drainage regimes
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk "The assessment of success was performed by an investigator blinded to allocation"
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Unclear if any LTFU‐ not stated in paper and no response from study authors
Selective reporting (reporting bias) High risk Minimal data provided on side effect and mortality data. Not all time points reported as stated in methods
Other bias Low risk No other sources of bias identified